$210 Million is the total value of Anfield Capital Management, LLC's 90 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 4.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRtr unit | $26,605,000 | -3.1% | 74,488 | +2.3% | 12.68% | +2.1% |
| XLP | Buy | SELECT SECTOR SPDR TRsbi cons stpls | $17,760,000 | -5.3% | 266,143 | +2.4% | 8.46% | -0.3% |
| XLK | Buy | SELECT SECTOR SPDR TRtechnology | $16,390,000 | -4.5% | 137,984 | +2.2% | 7.81% | +0.6% |
| XLV | Buy | SELECT SECTOR SPDR TRsbi healthcare | $15,616,000 | -3.2% | 128,941 | +2.5% | 7.44% | +1.9% |
| XLE | Buy | SELECT SECTOR SPDR TRenergy | $12,640,000 | +3.1% | 175,504 | +2.4% | 6.02% | +8.6% |
| DALT | Buy | TWO RDS SHARED TRanfield cap di | $9,437,000 | -7.3% | 1,145,262 | +0.2% | 4.50% | -2.4% |
| XLI | Buy | SELECT SECTOR SPDR TRsbi int-inds | $8,728,000 | -2.9% | 105,361 | +2.3% | 4.16% | +2.2% |
| XLU | Buy | SELECT SECTOR SPDR TRsbi int-utils | $6,164,000 | -4.4% | 94,094 | +2.4% | 2.94% | +0.7% |
| IWP | Buy | ISHARES TRrus md cp gr etf | $4,802,000 | +0.2% | 61,227 | +1.2% | 2.29% | +5.5% |
| JNK | Buy | SPDR SER TRbloomberg brclys | $4,204,000 | -0.6% | 47,853 | +2.6% | 2.00% | +4.7% |
| XLB | Buy | SELECT SECTOR SPDR TRsbi materials | $2,517,000 | -5.2% | 37,016 | +2.6% | 1.20% | -0.2% |
| ARCC | Buy | ARES CAPITAL CORP | $2,442,000 | -3.9% | 144,682 | +2.0% | 1.16% | +1.2% |
| FEI | Buy | FIRST TR MLP & ENERGY INCOME | $2,092,000 | -6.8% | 292,557 | +0.2% | 1.00% | -1.9% |
| SCHA | Buy | SCHWAB STRATEGIC TRus sml cap etf | $2,034,000 | -2.0% | 53,799 | +1.0% | 0.97% | +3.2% |
| IXJ | Buy | ISHARES TRglob hlthcre etf | $1,643,000 | -6.0% | 21,800 | +1.2% | 0.78% | -1.0% |
| MINT | Buy | PIMCO ETF TRenhan shrt ma ac | $492,000 | +0.8% | 4,978 | +1.0% | 0.24% | +6.3% |
| Buy | TWO RDS SHARED TRregents pk hdgd | $458,000 | -0.4% | 53,405 | +2.7% | 0.22% | +4.8% | |
| JPST | Buy | J P MORGAN EXCHANGE-TRADED Fultra shrt inc | $428,000 | +43.1% | 8,538 | +43.3% | 0.20% | +51.1% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $360,000 | +6.5% | 1,243 | +3.6% | 0.17% | +12.4% |
| MRK | Buy | MERCK & CO. INC | $337,000 | -2.3% | 3,915 | +3.6% | 0.16% | +3.2% |
| New | BLACKSTONE SECD LENDING FD | $321,000 | – | 14,135 | +100.0% | 0.15% | – | |
| REGN | Buy | REGENERON PHARMACEUTICALS | $315,000 | +20.7% | 457 | +3.6% | 0.15% | +27.1% |
| AAPL | Buy | APPLE INC | $279,000 | +2.2% | 2,019 | +1.3% | 0.13% | +7.3% |
| ABBV | Buy | ABBVIE INC | $262,000 | -9.3% | 1,955 | +3.5% | 0.12% | -4.6% |
| BNTX | Buy | BIONTECH SEsponsored ads | $246,000 | -6.1% | 1,823 | +3.6% | 0.12% | -1.7% |
| TSLA | New | TESLA INC | $211,000 | – | 795 | +100.0% | 0.10% | – |
| MRNA | Buy | MODERNA INC | $210,000 | -13.9% | 1,773 | +3.7% | 0.10% | -9.1% |
| FRA | Buy | BLACKROCK FLOATING RATE INCO | $198,000 | -2.0% | 17,990 | +1.7% | 0.09% | +3.3% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $177,000 | -9.7% | 862 | +3.2% | 0.08% | -5.6% |
| INCY | Buy | INCYTE CORP | $132,000 | -9.6% | 1,976 | +3.1% | 0.06% | -4.5% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $120,000 | -20.5% | 1,947 | +3.2% | 0.06% | -16.2% |
| CHE | Buy | CHEMED CORP NEW | $71,000 | -5.3% | 163 | +2.5% | 0.03% | 0.0% |
| EXEL | Buy | EXELIXIS INC | $55,000 | -23.6% | 3,531 | +2.7% | 0.03% | -21.2% |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $52,000 | +85.7% | 4,078 | +2.4% | 0.02% | +92.3% |
| BKT | Buy | BLACKROCK INCOME TR INC | $52,000 | -1.9% | 12,589 | +7.5% | 0.02% | +4.2% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $45,000 | -6.2% | 1,132 | +3.6% | 0.02% | -4.5% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $26,000 | +13.0% | 391 | +4.8% | 0.01% | +20.0% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $19,000 | -5.0% | 1,799 | +3.3% | 0.01% | 0.0% |
| AMPH | Buy | AMPHASTAR PHARMACEUTICALS IN | $17,000 | -19.0% | 614 | +3.5% | 0.01% | -20.0% |
| INVA | Buy | INNOVIVA INC | $16,000 | -20.0% | 1,386 | +2.7% | 0.01% | -11.1% |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $15,000 | -21.1% | 790 | +3.7% | 0.01% | -22.2% |
| QURE | Buy | UNIQURE NV | $14,000 | +7.7% | 751 | +5.8% | 0.01% | +16.7% |
| EBS | Buy | EMERGENT BIOSOLUTIONS INC | $11,000 | -26.7% | 508 | +3.7% | 0.01% | -28.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST | 16 | Q3 2023 | 19.6% |
| TWO RDS SHARED TR | 16 | Q3 2023 | 13.6% |
| TECHNOLOGY SELECT SECTOR SPDR FUND | 16 | Q3 2023 | 8.9% |
| SELECT SECTOR SPDR TR | 16 | Q3 2023 | 10.9% |
| TWO RDS SHARED TR | 16 | Q3 2023 | 5.9% |
| INVESCO FUNDAMENTAL HIGH YIELD CORPORATE BOND ETF | 16 | Q3 2023 | 3.5% |
| JP MORGAN EXCHANGE TRADED FD | 16 | Q3 2023 | 5.0% |
| PIMCO ETF TR | 16 | Q3 2023 | 4.7% |
| ARES CAPITAL CORPORATION | 16 | Q3 2023 | 1.6% |
| FIRST TRUST EXCHANGE-TRADED FUND III-FIRST TRUST | 16 | Q3 2023 | 1.2% |
View Anfield Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR/A | 2023-05-16 |
| 13F-HR | 2023-05-04 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-09 |
| 13F-HR/A | 2022-05-13 |
View Anfield Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.